Apadenoson SPECT-MPI

DRUG2 trials

Sponsors

Forest Laboratories

Conditions

Coronary Artery Disease

Phase 3

Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI

TerminatedNCT00990327

Forest LaboratoriesCoronary Artery Disease

Start: 2009-11-30End: 2012-04-30Updated: 2012-05-01

Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI

TerminatedNCT01313572

Forest LaboratoriesCoronary Artery Disease

Start: 2011-08-31End: 2012-04-30Updated: 2012-05-01